Kaoru Iwata

494 total citations
36 papers, 340 citations indexed

About

Kaoru Iwata is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Kaoru Iwata has authored 36 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 14 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Kaoru Iwata's work include Liver Disease Diagnosis and Treatment (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Liver Disease and Transplantation (6 papers). Kaoru Iwata is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Liver Disease and Transplantation (6 papers). Kaoru Iwata collaborates with scholars based in Japan, South Korea and Greece. Kaoru Iwata's co-authors include Tetsuro Sohda, Shotaro Sakisaka, Makoto Irie, Seiichiro Kamimura, Akira Anan, Yasuaki Takeyama, Daisuke Morihara, Hiroshi Watanabe, Keiji Yokoyama and Satoshi Shakado and has published in prestigious journals such as International Journal of Cancer, Gastrointestinal Endoscopy and Digestive Diseases and Sciences.

In The Last Decade

Kaoru Iwata

35 papers receiving 321 citations

Peers

Kaoru Iwata
Kristin Wahl Germany
Kaoru Iwata
Citations per year, relative to Kaoru Iwata Kaoru Iwata (= 1×) peers Kristin Wahl

Countries citing papers authored by Kaoru Iwata

Since Specialization
Citations

This map shows the geographic impact of Kaoru Iwata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaoru Iwata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaoru Iwata more than expected).

Fields of papers citing papers by Kaoru Iwata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaoru Iwata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaoru Iwata. The network helps show where Kaoru Iwata may publish in the future.

Co-authorship network of co-authors of Kaoru Iwata

This figure shows the co-authorship network connecting the top 25 collaborators of Kaoru Iwata. A scholar is included among the top collaborators of Kaoru Iwata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaoru Iwata. Kaoru Iwata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakamoto, Atsuhiko, et al.. (2022). Maoto, a traditional herbal medicine, for post-exposure prophylaxis for Japanese healthcare workers exposed to COVID-19: A single center study. Journal of Infection and Chemotherapy. 28(7). 907–911. 6 indexed citations
2.
Sohda, Tetsuro, Kaoru Iwata, Keiji Yokoyama, et al.. (2013). 3-Hydroxyl-3-methylglutaryl-coenzyme A reductase is up regulated in hepatocellular carcinoma associated with paraneoplastic hypercholesterolemia. Medical Molecular Morphology. 46(4). 239–242. 8 indexed citations
3.
Yokoyama, Keiji, Akira Anan, Kaoru Iwata, et al.. (2012). Limitation of repeated radiofrequency ablation in hepatocellular carcinoma: Proposal of a three (times) ×  3 (years) index. Journal of Gastroenterology and Hepatology. 27(6). 1044–1050. 9 indexed citations
4.
Sohda, Tetsuro, Atsushi Fukunaga, H Iwashita, et al.. (2012). Systemic Chemotherapy Using Carboplatin and 5-Fluorouracil for Extrahepatic Metastasis of Hepatocellular Carcinoma. Hepatogastroenterology. 59(119). 2264–8. 4 indexed citations
5.
Shakado, Satoshi, Yuko Akehi, Atsushi Fukunaga, et al.. (2011). A case of hepatitis C-associated osteosclerosis that was improved with the combination therapy of peginterferon alfa-2b and ribavirin. Clinical Journal of Gastroenterology. 4(4). 255–261. 3 indexed citations
6.
Irie, Makoto, Keiji Yokoyama, Daisuke Morihara, et al.. (2010). Patient with drug-induced hepatic injury with sever bilirubinemia due to long-term administration of Amlodipine and Loxoprofen Na. Kanzo. 51(4). 169–174.
7.
Morihara, Daisuke, Yasuaki Takeyama, Shinya Nishizawa, et al.. (2009). A Case of Acute Pancreatitis Associated with a Severe Acute HAV Infection and Compensated Liver Cirrhosis Type B. 36(2). 135–139. 1 indexed citations
8.
Tanaka, Takashi, Satoshi Shakado, Daisuke Morihara, et al.. (2008). The prognostic factors of sustained virologic response among patients of chronic hepatitis C treated with peg-interferon alpha 2a monotherapy. Kanzo. 49(9). 417–425. 3 indexed citations
9.
Takeyama, Yasuaki, Takashi Tanaka, Shuichi Ueda, et al.. (2008). Budd-Chiari Syndrome: Two Cases with Different Courses. Case Reports in Gastroenterology. 2(2). 256–261. 1 indexed citations
10.
Shakado, Satoshi, Hiroshi Watanabe, Takashi Tanaka, et al.. (2008). Combination therapy of lamivudine and adefovir in Japanese patients with chronic hepatitis B. Hepatology International. 2(3). 361–369. 8 indexed citations
11.
Sohda, Tetsuro, Kaoru Iwata, Makoto Irie, et al.. (2008). Spontaneous rupture of metastatic α-fetoprotein-producing gastric cancer of the liver. Hepatology International. 2(2). 258–261. 9 indexed citations
12.
Tanaka, Yoïchi, Tetsuro Sohda, Katsuhiko Matsuo, et al.. (2007). Vascular endothelial growth factor reduces Fas‐mediated acute liver injury in mice. Journal of Gastroenterology and Hepatology. 23(7pt2). e207–11. 8 indexed citations
13.
Sohda, Tetsuro, Kaoru Iwata, Yuji Kitamura, et al.. (2007). Reduced expression of low‐density lipoprotein receptor in hepatocellular carcinoma with paraneoplastic hypercholesterolemia. Journal of Gastroenterology and Hepatology. 23(7pt2). e153–6. 18 indexed citations
14.
Anan, Akira, Makoto Irie, Hiroshi Watanabe, et al.. (2006). Colonic varices treated by balloon-occluded retrograde transvenous obliteration in a cirrhotic patient with encephalopathy: a case report. Gastrointestinal Endoscopy. 63(6). 880–884. 27 indexed citations
15.
Aoyagi, Kunihiko, et al.. (2005). Double Doses of Secretin Contribute to Diagnosis of Zollinger–Ellison Syndrome in Secretin and Selective Arterial Secretion Injection Tests—A Case Report. Digestive Diseases and Sciences. 50(11). 2034–2036. 3 indexed citations
16.
Matsumoto, Teruo, Hiroshi Watanabe, Makoto Irie, et al.. (2004). Nonalcoholic steatohepatitis associated with psoriasis vulgaris. Journal of Gastroenterology. 39(11). 1102–1105. 14 indexed citations
18.
Kamimura, Seiichiro, Junichi Takada, Kaoru Iwata, et al.. (1998). CASE REPORT: Insulin ‐ like growth factor II expression in hepatocellular carcinoma with alcoholic liver fibrosis accompanied by hypoglycaemia. Journal of Gastroenterology and Hepatology. 13(1). 47–51. 12 indexed citations
19.
Lee, Hyo‐Suk, et al.. (1997). Lack of association of cytochrome P450 2E1 genetic polymorphisms with the risk of human hepatocellular carcinoma. International Journal of Cancer. 71(5). 737–740. 37 indexed citations
20.
Sohda, Tetsuro, Seiichiro Kamimura, Kaoru Iwata, Hiroshi Shijo, & Makoto Okumura. (1997). Immunohistochemical evidence of insulin‐like growth factor II in human small hepatocellular carcinoma with hepatitis C virus infection: Relationship to fatty change in carcinoma cells. Journal of Gastroenterology and Hepatology. 12(3). 224–228. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026